Confirmed Control Announced Transaction verified Aesthetic InjectablesBiopharmaceuticalsLife Sciences Medical AestheticsMedical Aesthetics
KYTHERA Biopharmaceuticals acquired by Allergan
Allergan agreed to acquire KYTHERA Biopharmaceuticals, a life sciences medical aesthetics brand on Jun 17, 2015. The transaction value is shown as USD 2.1bn. Public sources confirm the deal; valuation inputs may include estimates where transaction materials do not disclose the full economics.
Transaction summary
- Target
- KYTHERA Biopharmaceuticals
- Acquirer
- Allergan
- Seller
- -
- Announced
- 2015-06-17
- Geography
- -
- Tags
- Aesthetic InjectablesBiopharmaceuticalsLife Sciences Medical AestheticsMedical Aesthetics
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
Price / value
USD 2.1B
Consideration | USD
Basis: Public source
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- USD 2.1bn consideration is treated as publicly disclosed or derived directly from public source data.
Source summary
No public source summary has been published for this transaction yet.